Revitalist CEO Kathryn Walker on ideas for rapid expansion, continuing with the opening of several new clinics in strategic locations.
Continue readingRevitalist CEO Kathryn Walker Says 2022 Will Be A Year For Execution In Psychedelics
Study Finds 65% Of Americans With Mental Health Conditions Want Access To Psychedelics
Respondents said that if plant medicines were “proven more effective than prescription medication with fewer side effects,” 66% would try ketamine, 62% would try psilocybin, and 56% would try MDMA.
Continue readingMicrodose Psychedelic Insights to Host Psychedelic Capital: January 2022 Conference, Featuring Heroic Hearts Project, Entheo Digital, PurMinds NeuroPharma, Public Vs Private Markets and 2022 Predictions
Toronto, Ontario–(Newsfile Corp. – January 18, 2022) – Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be hosting the upcoming Psychedelic Capital: January 2022 Conference in an entirely virtual format on January 27th, 2022 starting at 1:30pm EST. The virtual event will provide attendees with access to some of the top companies, latest IPOs, newest opportunities and deepest industry insights within the psychedelics sector.As part of a bi-monthly investor c
Continue readingMicrodose Psychedelic Insights to Host Psychedelic Capital: January 2022 Conference, Featuring Heroic Hearts Project, Entheo Digital, Public vs Private Markets and 2022 Predictions
NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be…
Continue reading